Cardiovascular Disease Doctors in Kalamazoo, MI Accepting Medicare

30 Cardiovascular Disease doctors found. Showing 1 - 20

Dr. Christopher Rogers, D.O. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Ste 100, Kalamazoo, MI 49007 Phone: 269-373-1222    Fax: 269-373-6270

Dr. Michael S. Pawlik, D.O. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Ste 100, Kalamazoo, MI 49007 Phone: 269-373-1592    Fax: 269-373-6270

Dr. Santhosh Koshy, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1722 Shaffer St Ste 1, Kalamazoo, MI 49048 Phone: 269-381-3963

Dr. Stephen L Peck, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1717 Shaffer St, Suite 232, Kalamazoo, MI 49048 Phone: 269-226-5050    Fax: 269-226-5034

Dr. William Frances Lapenna, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1717 Shaffer St, Suite 232, Kalamazoo, MI 49048 Phone: 269-226-5050    Fax: 269-226-5034

Dr. John F Schonder, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Ste 100, Kalamazoo, MI 49007 Phone: 269-373-1592    Fax: 269-373-6270

Dr. Anthony King, Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1722 Shaffer St, Suite 1, Kalamazoo, MI 49048 Phone: 269-381-3963    Fax: 269-381-2809

Frank S Saltiel, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1722 Shaffer St, Suite 1, Kalamazoo, MI 49048 Phone: 269-381-3963

Dr. Benjamin Allan Perry, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 601 John St, Suite M230, Kalamazoo, MI 49007 Phone: 269-345-9606    Fax: 269-373-7095

Theodore S Varas, DO Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 601 John Street, Suite M302, Kalamazoo, MI 49007 Phone: 269-341-7070    Fax: 269-341-7244

Ryan Jamoua, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1521 Gull Rd, Kalamazoo, MI 49048 Phone: 269-226-7000

Dr. Gregorio Tan, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1722 Shaffer St, Suite 1, Kalamazoo, MI 49048 Phone: 269-381-3963    Fax: 269-381-2809

Dr. Joel H Reinoehl, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Ste 100, Kalamazoo, MI 49007 Phone: 269-373-1592    Fax: 269-373-6270

Dr. David William Burke, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 601 John St, Suite M230, Kalamazoo, MI 49007 Phone: 269-345-9606    Fax: 269-373-7095

Dr. Jessica Delois Williams, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1722 Shaffer St, Kalamazoo, MI 49048 Phone: 269-381-3963

Pranay Vamsikrishna Pandrangi, BS, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 601 John St Ste 100, Kalamazoo, MI 49007 Phone: 269-373-1222

Dr. Philip L Dawson, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1535 Gull Rd, Suite 205, Kalamazoo, MI 49048 Phone: 269-381-3521    Fax: 269-381-4703

Michael A Pack, DO Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Suite 100, Kalamazoo, MI 49007 Phone: 269-373-1592    Fax: 269-373-6270

Dr. Ronald James Zegerius, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Suite M230, Kalamazoo, MI 49007 Phone: 269-345-9606    Fax: 269-373-7095

Dr. Alicia M Williams, Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1722 Shaffer St, Suite 1, Kalamazoo, MI 49048 Phone: 269-381-3963    Fax: 269-381-2809

News Archive

New pluripotent stem cell technology provides insights into neuropsychiatric disorders

Studying the genetic code allows researchers to know whether some patients with neuropsychiatric disorders either have extra copies of the CHRNA7 gene or are missing copies. However, little was known about the functional consequences of this genetic imbalance in brain cells.

Merck challenges New York jury decision in federal FOSAMAX retrial

Merck & Co., Inc. today said it is challenging the decision returned by a New York jury in the retrial of a federal FOSAMAX case, Boles v. Merck. This case was the Plaintiffs' Steering Committee's top choice to take to trial and involved a Florida woman who blamed her dental and jaw problems on FOSAMAX. The first case to reach a verdict, Maley v. Merck, resulted in a defense verdict for Merck on May 5, 2010.

Children's age at school entry may have effect on ADHD diagnosis

Attention-deficit hyperactivity disorder (ADHD) is typically diagnosed in childhood and manifests as an inability to sustain attention and control activity levels and impulse control. Some reports have indicated a prevalence of up to 15% in Western countries. Although the causes of ADHD are still unknown, a new study scheduled for publication in The Journal of Pediatrics found that a child's age at school entry may have an effect on the diagnosis of ADHD

ATCC and One Codex form partnership to address microbiome research needs

ATCC, a global leader in biological materials development, management and standards, and One Codex, a leading microbial genomics and metagenomics platform, today announced the formation of a partnership to address microbiome research needs.

Vestar affiliate to acquire HealthGrades

Vestar Capital Partners V, L.P. and Health Grades, Inc. today announced a definitive agreement for an affiliate of Vestar to acquire all of the outstanding shares of HealthGrades for $8.20 per share, which represents a premium of approximately 32% over HealthGrades' 30-day average closing stock price, and a premium of approximately 29% over the closing price of HealthGrades' common stock on July 27, 2010, the last trading day prior to today's announcement.

Read more Medical News

› Verified 1 days ago

• 1(current)
• 2